Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Erinyes
    Junior Member
    • Oct 2012
    • 9

    #1

    DESeq2: bad experimental design and "not full rank" problems

    Hi all.

    In my lab, we have some old RNA-seq data that were produced by other users in the past. The experimental design was completely wrong, but I would like to analyze them in order to decide whether I should repeat the experiments or drop the whole idea altogether. I have already tried a few things, but I am afraid that all I see is technical noise.

    Code:
    Sample	Condition	Prep	Treatment
    1	KD	A	shRNA
    2	KD	A	shRNA
    3	KD	A	shRNA
    4	ctrl	B	shRNA
    5	ctrl	B	shRNA
    6	ctrl	B	shRNA
    7	ctrl	B	shRNA
    8	wt	C	no
    9	wt	C	no
    10	wt	C	no
    11	wt	C	no
    12	wt	C	no
    13	wt	C	no
    14	wt	C	no
    I have performed DE analysis of KD vs ctrl and I got 1200 DE genes. Using contrasts, I have check wt vs ctrl and I got 70 DE genes. However, the general profile of both comparisons seems very similar (through heatmaps). Is there a way to correct for the different preps? I have seen in my recent data that the batch effect can be huge, but is there a way to extract some meaningful information from this set of data? Or it’s not worth trying to make sense of them at all?

    When I tried ~ Treatment*Condition or ~ Prep + Condition, I got the error that the model matrix is not full rank (obviously).

    Any suggestions will be greatly appreciated, or any experiences with problematic experimental designs!

    Cheers
    --Katerina
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    If you happen to have a set of genes that you know a prioi to be constantly expressed regardless of treatment then you could use those for normalization and correcting the batch effect correction. If not, there's nothing you can do.

    Comment

    • Erinyes
      Junior Member
      • Oct 2012
      • 9

      #3
      Yes, I was afraid of that.

      I have already considered such a solution, but I do not really *know* of such genes. I can make some educated guesses but that's about it.

      Thanks anyway.
      --Katerina

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:13 AM
      0 responses
      14 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Working...